Explanation for the observed protective effects of IPC. Studies by Patschan and colleagues [13] showed that the late phase of IPC facilitates EPC mobilization to the ischemic kidney, and accumulation of EPCs in the kidney is at least partially responsible for the beneficial effects of IPC. purchase PS-1145 However, the interval between preischemia and ischemic injury is too long for a clinical application of the protocol. In the present study, the early phase of IPC significantly increased the number of EPCs in the ischemic kidney and afforded partial renoprotection following PN. These findings provide evidence for EPCs modulation by the early phase of IPC, which attenuates IRI, and are in agreement with the reports of LiFigure 9. Relative expression of VEGF-A (6 h) and SDF-1a (24 h) protein. Protein expression was assessed by Western blot analyses using b-actin as a sample loading control. VEGF-A level was significantly higher in the IPC rats compared with that in the PN or Sham group (P,0.05). However, there were no significant differences between VEGF-A levels in the PN and Sham groups. Although SDF-1a expression was significantly increased in the PN group when compared to the Sham group, the IPC group showed a greater increase in SDF-1a expression when compared to the PN group. Data are shown as mean 6 SEM. *Significant difference vs. Sham group (P,0.05); #significant difference vs. PN group (P,0.05). doi:10.1371/journal.pone.0055389.get al. [14] who stated that acute myocardial ischemia may be alleviated by EPC recruitment during the early phase of IPC. Renal IRI refers 1527786 to a complex disorder that comprises multiple causative factors [32]. Tubular epithelial cells dedifferentiate, proliferate and replace the injured epithelial cells during recovery from IRI; loss of tubular epithelial cells is of key importance for the pathophysiological consequences of the syndrome [33,34]. Recent studies also found that endothelial cells in peritubular capillaries play an important role in renal IRI, where there is swelling, blebbing, death, and detachment of viable cells, leading to impairment of the microcirculation following IRI. These phenomenon, described as “no-reflow,” were proposed to be responsible for a delayed functional recovery of the post-ischemic kidney [32,35]. Furthermore, infusion of endothelial cells into rats subjected to renal artery clamping led to improvement of 15857111 renal microcirculation and mitigation of the organ dysfunction [36]. It is encouraging that EPCs play a fundamental role in cell regeneration and vascular repair [9]. The present study showed that the number of EPCs in the kidneys is modulated by IPC and promotes proliferation of endothelial and epithelial cells one day following surgery. This was Fruquintinib demonstrated using immunochemistry, which detected a large number of PCNA+ cells in the medullopapillary region. In addition, there was a significant increase in angiogenesis with preconditioned rats, as measured by PCRI. EPCs at least partially participate in neovascularization and cell regeneration that may be critical to recovery from ischemic injury. The mechanisms could be attributed to incorporation into the injured cells and paracrine effects [37?0]. Previous studies showed that only low numbers of EPCs could be identified as incorporating into the new capillaries following EPC transplantation, suggesting that EPCs do not act via direct incorporation into the injured cells, but rather by a paracrine mechanism [41,42]. Previous stu.Explanation for the observed protective effects of IPC. Studies by Patschan and colleagues [13] showed that the late phase of IPC facilitates EPC mobilization to the ischemic kidney, and accumulation of EPCs in the kidney is at least partially responsible for the beneficial effects of IPC. However, the interval between preischemia and ischemic injury is too long for a clinical application of the protocol. In the present study, the early phase of IPC significantly increased the number of EPCs in the ischemic kidney and afforded partial renoprotection following PN. These findings provide evidence for EPCs modulation by the early phase of IPC, which attenuates IRI, and are in agreement with the reports of LiFigure 9. Relative expression of VEGF-A (6 h) and SDF-1a (24 h) protein. Protein expression was assessed by Western blot analyses using b-actin as a sample loading control. VEGF-A level was significantly higher in the IPC rats compared with that in the PN or Sham group (P,0.05). However, there were no significant differences between VEGF-A levels in the PN and Sham groups. Although SDF-1a expression was significantly increased in the PN group when compared to the Sham group, the IPC group showed a greater increase in SDF-1a expression when compared to the PN group. Data are shown as mean 6 SEM. *Significant difference vs. Sham group (P,0.05); #significant difference vs. PN group (P,0.05). doi:10.1371/journal.pone.0055389.get al. [14] who stated that acute myocardial ischemia may be alleviated by EPC recruitment during the early phase of IPC. Renal IRI refers 1527786 to a complex disorder that comprises multiple causative factors [32]. Tubular epithelial cells dedifferentiate, proliferate and replace the injured epithelial cells during recovery from IRI; loss of tubular epithelial cells is of key importance for the pathophysiological consequences of the syndrome [33,34]. Recent studies also found that endothelial cells in peritubular capillaries play an important role in renal IRI, where there is swelling, blebbing, death, and detachment of viable cells, leading to impairment of the microcirculation following IRI. These phenomenon, described as “no-reflow,” were proposed to be responsible for a delayed functional recovery of the post-ischemic kidney [32,35]. Furthermore, infusion of endothelial cells into rats subjected to renal artery clamping led to improvement of 15857111 renal microcirculation and mitigation of the organ dysfunction [36]. It is encouraging that EPCs play a fundamental role in cell regeneration and vascular repair [9]. The present study showed that the number of EPCs in the kidneys is modulated by IPC and promotes proliferation of endothelial and epithelial cells one day following surgery. This was demonstrated using immunochemistry, which detected a large number of PCNA+ cells in the medullopapillary region. In addition, there was a significant increase in angiogenesis with preconditioned rats, as measured by PCRI. EPCs at least partially participate in neovascularization and cell regeneration that may be critical to recovery from ischemic injury. The mechanisms could be attributed to incorporation into the injured cells and paracrine effects [37?0]. Previous studies showed that only low numbers of EPCs could be identified as incorporating into the new capillaries following EPC transplantation, suggesting that EPCs do not act via direct incorporation into the injured cells, but rather by a paracrine mechanism [41,42]. Previous stu.
